Today's Market Winners and Losers

Before you go, we thought you'd like these...
Before you go close icon

The stock market is up Friday, with the Dow Jones Industrial Average up 0.33%, the Nasdaq up 0.59% and the S&P 500 up 0.43%. Today's winners include a pharmaceutical company that received good news from the Food and Drug Administration and a home builder that beat Wall Street earnings expectations. Today's losers include a pharmaceutical company who may not get European approval for a drug and a well-known mobile company that experienced outages overseas.

These are Friday's market winners and losers.

Biggest Winners

Shares of Halozyme Therapeutics Inc. (NASDAQ: HALO) are up 26.52% to $8.11 on trading volume of 2 million shares. The U.S. Food and Drug Administration has provided guidance to Halozyme and ViroPharma Inc. (NASDAQ: VPHM) to resume clinical studies of the drug Cinryze. The 52-week high is $13.50.

Shares of KB Home (NYSE: KBH) are up 9.38% to $14.34 on trading volume of 7 million shares. The company earned 4 cents a share in the third quarter, better than a loss of 12 cents a share that Wall Street analysts polled by Reuters were expecting. Before Friday, the 52-week high was $13.65.

Biggest Losers

Shares of VIVUS Inc. (NASDAQ: VVUS) are down 10.58% to $21.21 on trading volume of 4.7 million shares. The pharmaceutical company is concerned that European regulators will reject its anti-obesity drug. The 52-week low is $7.47.

Shares of Research In Motion Ltd. (NASDAQ: RIMM) are down 5.58% to $6.52 on trading volume of 10.4 million shares. Blackberry suffered service outages in Europe, the Middle East and Africa. The 52-week low is $6.33.

Samuel Weigley

Follow him on Twitter: SWeigley


Filed under: 24/7 Wall St. Wire, Market Roundups, Most Actives Tagged: HALO, KBH, RIMM, VPHM, VVUS
Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners